MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Short Term Borrowings History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Short Term Borrowings | ₹2,513 Cr | ₹151 Cr | ₹115 Cr | ₹795 Cr | ₹158 Cr |
What is the latest Short Term Borrowings ratio of MANKIND PHARMA ?
| Year | Short Term Borrowings |
|---|---|
| Mar2025 | ₹2,513 Cr |
| Mar2024 | ₹151 Cr |
| Mar2023 | ₹115 Cr |
| Mar2022 | ₹795 Cr |
| Mar2021 | ₹158 Cr |
How is Short Term Borrowings of MANKIND PHARMA Trending?
| Years | Short Term Borrowings | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,513 Cr | 1,559.06 | |
| Mar2024 | ₹151 Cr | 31.70 | |
| Mar2023 | ₹115 Cr | -85.52 | |
| Mar2022 | ₹795 Cr | 401.78 | |
| Mar2021 | ₹158 Cr | - | |
Compare Short Term Borrowings of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹88,487.8 Cr | 3.1% | 2.5% | -9.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,209.0 Cr | 1% | -6.4% | -0.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,750.0 Cr | 3.5% | 3.4% | 11.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,746.0 Cr | 0.2% | -1.8% | 33.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,851.0 Cr | -0.2% | -3.4% | 11.4% | Stock Analytics | |
| CIPLA | ₹99,268.4 Cr | 1.5% | -5.4% | -15.4% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 3.1% |
2.5% |
-9.7% |
| SENSEX | 1.3% |
5.3% |
6.3% |
You may also like the below Video Courses